Global /India /Healthcare /Biotechnology /AKUMS
chevron_leftBack
Akums Drugs and Pharmaceuticals Ltd. logo

Akums Drugs and Pharmaceuticals Ltd.

AKUMS
NSE: AKUMS Delayed
547.30INR 0.7%
5.74 USD
As of 7 June 2026, Akums Drugs and Pharmaceuticals Ltd. has a market cap of $869.35M USD, ranking #11561 globally and #630 in India. It ranks #1049 in the Healthcare sector, and #195 in the Biotechnology industry.
Global Rank
11561
Country Rank
630
Sector Rank
1049
Industry Rank
195
Key Stats
Market Cap
$869.35MUSD
83.24B INR
Enterprise Value
$710.79MUSD
67.8B INR
Revenue (TTM)
$444.87MUSD
42.6B INR
EBITDA (TTM)
$50.06MUSD
4.78B INR
Net Income (TTM)
$33.23MUSD
3.18B INR
EBITDA Margin
11%
Profit Margin
7.5%
PE Ratio
26.2
Forward PE
23.7
PS Ratio
2.0
PB Ratio
2.6
EV/EBITDA
13.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
Employees
7,536
Founded
2004
Website
akums.in open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0.7% 2.8% 15% 26% 19% 3.7%

News

Loading...

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
AKUMS
Akums Drugs and Pharmaceuticals Ltd
ISIN: INE09XN01023
Shares Out.:
157.394M1 Shares Float: 36.899M2
TV:
SA:
YF:
GF:
BA:
MS:
547.30 INR
Bombay Stock Exchange
MIC: XBOM
544222 (AKUMS)
Akums Drugs and Pharmaceuticals Ltd
ISIN: INE09XN01023
TV:
SA:
YF:
GF:
BA:
MS:
543.15 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Akums Drugs and Pharmaceuticals Ltd.

Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. The company provides drugs, ayurvedic, herbals, toiletries, nutraceuticals, food and dietary supplements, derma and cosmetics, healthcare and hospital products, over-the-counter (OTC) products, active pharmaceutical ingredients, excipients, and compounds. It also offers branded formulations on various dosage forms, including tablets, capsules, injectables, opthalmics, and soft gelatin capsules for therapeutic areas, such as gynaecology, cardiology, orthopaedics, pediatrics, and dermatology, as well as anti-infectives, pain management and gastroenterology. In addition, the company operates as pharmaceutical contract development and manufacturing company. The company was incorporated in 2004 and is based in Delhi, India.

Similar Companies

Industry: Biotechnology (India)
Name
Market Cap diff.
PE
$4.55B
435.39B INR
423%
90.4
RUBICON
$1.68B
160.71B INR
93%
74.8
TITANBIO
$190.84M
18.27B INR
-78%
-
FERMENTA
$96.13M
9.2B INR
-89%
10.6
$79.49M
7.61B INR
-91%
17.1
SMSLIFE
$47.39M
4.54B INR
-95%
22.9
Industry: Biotechnology (Global)
Name
Market Cap diff.
PE
AMGN
$182.42B
21K%
23.9
GILD
$159.92B
18K%
19.0
ARGX
$48.08B
41.39B EUR
5K%
39.9
$44.48B
68.19T KRW
5K%
35.5
CSL
$43.01B
60.27B AUD
5K%
29.3
LONN
$42.72B
33.71B CHF
5K%
37.2
chevron_leftBack